ShiA abrogates the innate T-cell response to Shigella flexneri infection

Infection and Immunity

Volumn 74, Issue 4, 2006, Pages 2317-2327

  Ingersoll, Molly A ^a,b,c   Zychlinsky, Arturo ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; SHIA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM CLEARANCE; BACTERIUM MUTANT; CELLULAR IMMUNITY; CLEARANCE; COLON INJURY; CONTROLLED STUDY; DISEASE MODEL; GENE OVEREXPRESSION; ILEAL LOOP MODEL; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE COUNT; LUNG INFECTION; LYMPHOCYTE COUNT; MICROARRAY ANALYSIS; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENICITY ISLAND; PLASMID; PRIORITY JOURNAL; RABBIT; SHI 2 PATHOGENICITY ISLAND; SHIA GENE; SHIGELLA FLEXNERI; SHIGELLOSIS; SURVIVAL; T LYMPHOCYTE;

ANIMALS; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DOWN-REGULATION; DYSENTERY, BACILLARY; GENE EXPRESSION PROFILING; IMMUNITY, NATURAL; INFLAMMATION MEDIATORS; LYMPHOCYTE COUNT; MICE; MICE, INBRED C57BL; NEUTROPHIL ACTIVATION; NEUTROPHIL INFILTRATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PNEUMONIA, BACTERIAL; SHIGELLA FLEXNERI; SURVIVAL ANALYSIS; T-LYMPHOCYTES; VIRULENCE FACTORS;

EID: 33645513238     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.4.2317-2327.2006     Document Type: Article

References (52)

1. Aggarwal, S., N. Ghilardi, M. H. Xie, F. J. de Sauvage, and A. L. Gurney. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278:1910-1914.
2. Agostini, C., M. Facco, M. Siviero, D. Carollo, S. Galvan, A. M. Cattelan, R. Zambello, L. Trentin, and G. Semenzato. 2000. CXC chemokines IP-10 and mig expression and direct migration of pulmonary CD8+/CXCR3+ T cells in the lungs of patients with HIV infection and T-cell alveolitis. Am. J. Respir. Crit. Care Med. 162:1466-1473.
3. Awane, M., P. G. Andres, D. J. Li, and H. C. Reinecker. 1999. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J. Immunol. 162:5337-5344.
4. Cardona, A. E., P. A. Gonzalez, and J. M. Teale. 2003. CC chemokines mediate leukocyte trafficking into the central nervous system during murine neurocysticercosis: role of γδ cells in amplification of the host immune response. Infect. Immun. 71:2634-2642.
5. Chen, Y., M. R. Smith, K. Thirumalai, and A. Zychlinsky. 1996. A bacterial invasin induces macrophage apoptosis by directly binding ICE. EMBO J. 15:3853-3860.
6. Connor, S. J., N. Paraskevopoulos, R. Newman, N. Cuan, T. Hampartzoumian, A. R. Lloyd, and M. C. Grimm. 2004. CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease. Gut 53:1287-1294.
7. Davies, A., S. Lopez-Briones, H. Ong, C. O'Neil-Marshall, F. A. Lemonnier, K. Nagaraju, E. S. Metcalf, and M. J. Soloski. 2004. Infection-induced expansion of a MHC class Ib-dependent intestinal intraepithelial gamma-delta T cell subset. J. Immunol. 172:6828-6837.
8. Falkow, S., H. Schneider, L. S. Baron, and S. B. Formal. 1963. Virulence of Escherichia-Shigella genetic hybrids for the guinea pig. J. Bacteriol. 86:1251-1258.
9. Finlay, B. B., and S. Falkow. 1988. Comparison of the invasion strategies used by Salmonella cholerae-suis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: endosome acidification is not required for bacterial invasion or intracellular replication. Biochimie 70:1089-1099.
10. Hayday, A., E. Theodoridis, E. Ramsburg, and J. Shires. 2001. Intraepithelial lymphocytes: exploring the third way in immunology. Nat. Immunol. 2:997-1003.
11. Hayday, A., and R. Tigelaar. 2003. Immunoregulation in the tissues by gammadelta T cells. Nat. Rev. Immunol. 3:233-242.
12. Hilbi, H., Y. Chen, K. Thirumalai, and A. Zychlinsky. 1997. The interleukin 1β-converting enzyme, caspase 1, is activated during Shigella flexneri-induced apoptosis in human monocyte-derived macrophages. Infect. Immun. 65:5165-5170.
13. Hilbi, H., J. E. Moss, D. Hersh, Y. Chen, J. Arondel, S. Banerjee, R. A. Flavell, J. Yuan, P. J. Sansonetti, and A. Zychlinsky. 1998. Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB. J. Biol. Chem. 273:32895-32900.
14. Ingersoll, M. A., J. E. Moss, Y. Weinrauch, P. E. Fisher, E. A. Groisman, and A. Zychlinsky. 2003. The ShiA protein encoded by the Shigella flexneri SHI-2 pathogenicity island attenuates inflammation. Cell. Microbiol. 5:797-807.
15. Islam, D., and B. Christensson. 2000. Disease-dependent changes in T-cell populations in patients with shigellosis. APMIS 108:251-260.
16. Jarry, A., M. Robaszkiewicz, N. Brousse, and F. Potet. 1989. Immune cells associated with M cells in the follicle-associated epithelium of Peyer's patches in the rat. Cell Tissue Res. 255:293-298.
17. Jovanovic, D. V., J. A. Di Battista, J. Martel-Pelletier, F. C. Jolicoeur, Y. He, M. Zhang, F. Mineau, and J. P. Pelletier. 1998. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol. 160:3513-3521.
18. Kolls, J. K., and A. Linden. 2004. Interleukin-17 family members and inflammation. Immunity 21:467-476.
19. Kotloff, K. L., J. P. Winickoff, B. Ivanoff, J. D. Clemens, D. L. Swerdlow, P. J. Sansonetti, G. K. Adak, and M. M. Levine. 1999. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. W. H. O. 77:651-666.
20. Le-Barillec, K., J. G. Magalhaes, E. Corcuff, A. Thuizat, P. J. Sansonetti, A. Phalipon, and J. P. Di Santo. 2005. Roles for T and NK cells in the innate immune response to Shigella flexneri. J. Immunol. 175:1735-1740.
21. Linden, A. 2001. Role of interleukin-17 and the neutrophil in asthma. Int. Arch. Allergy Immunol. 126:179-184.
22. Mandic-Mulec, I., J. Weiss, and A. Zychlinsky. 1997. Shigella flexneri is trapped in polymorphonuclear leukocyte vacuoles and efficiently killed. Infect. Immun. 65:110-115.
23. Maurelli, A. T., and P. J. Sansonetti. 1988. Genetic determinants of Shigella pathogenicity. Annu. Rev. Microbiol. 42:127-150.
24. McLoughlin, R. M., B. J. Jenkins, D. Grail, A. S. Williams, C. A. Fielding, C. R. Parker, M. Ernst, N. Topley, and S. A. Jones. 2005. IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. Proc. Natl. Acad. Sci. USA 102:9589-9594.
25. Miyamoto, M., O. Prause, M. Sjostrand, M. Laan, J. Lotvall, and A. Linden. 2003. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J. Immunol. 170:4665-4672.
26. Moss, J. E., T. J. Cardozo, A. Zychlinsky, and E. A. Groisman. 1999. The selC-associated SHI-2 pathogenicity island of Shigella flexneri. Mol. Microbiol. 33:74-83.
27. Mounier, J., T. Vasselon, R. Hellio, M. Lesourd, and P. J. Sansonetti. 1992. Shigella flexneri enters human colonic Caco-2 epithelial cells through the basolateral pole. Infect. Immun. 60:237-248.
28. + Th subsets polarized in vitro and in vivo. Infect. Immun. 71:6178-6183.
29. New, J. Y., B. Li, W. P. Koh, H. K. Ng, S. Y. Tan, E. H. Yap, S. H. Chan, and H. Z. Hu. 2002. T cell infiltration and chemokine expression: relevance to the disease localization in murine graft-versus-host disease. Bone Marrow Transplant. 29:979-986.
30. Niess, J. H., S. Brand, X. Gu, L. Landsman, S. Jung, B. A. McCormick, J. M. Vyas, M. Boes, H. L. Ploegh, J. G. Fox, D. R. Liftman, and H. C. Reinecker. 2005. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307:254-258.
31. Numasaki, M., M. T. Lotze, and H. Sasaki. 2004. Interleukin-17 augments tumor necrosis factor-alpha-induced elaboration of proangiogenic factors from fibroblasts. Immunol. Lett. 93:39-43.
32. Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, F. Zonin, E. Vaisberg, T. Churakova, M. Liu, D. Gorman, J. Wagner, S. Zurawski, Y. Liu, J. S. Abrams, K. W. Moore, D. Rennick, R. de Waal-Malefyt, C. Hannum, J. F. Bazan, and R. A. Kastelein. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715-725.
33. Perdomo, J. J., P. Gounon, and P. J. Sansonetti. 1994. Polymorphonuclear leukocyte transmigration promotes invasion of colonic epithelial monolayer by Shigella flexneri. J. Clin. Investig. 93:633-643.
34. Perdomo, O. J., J. M. Cavaillon, M. Huerre, H. Ohayon, P. Gounon, and P. J. Sansonetti. 1994. Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. J. Exp. Med. 180:1307-1319.
35. Sansonetti, P., A. Phalipon, J. Arondel, K. Thirumalai, S. Banerjee, S. Akira, K. Takeda, and A. Zychlinsky. 2000. Caspase-1 activation of IL-1β and IL-18 are essential for Shigella flexneri induced inflammation. Immunity 12:581-590.
36. Sansonetti, P. J. 1992. Molecular and cellular biology of Shigella flexneri invasiveness: from cell assay systems to shigellosis. Curr. Top. Microbiol. Immunol. 180:1-19.
37. Sansonetti, P. J., J. Arondel, J. M. Cavaillon, and M. Huerre. 1995. Role of interleukin-1 in the pathogenesis of experimental shigellosis. J. Clin. Investig. 96:884-892.
38. Sansonetti, P. J., J. Arondel, M. Huerre, A. Harada, and K. Matsushima. 1999. Interleukin-8 controls bacterial transepithelial translocation at the cost of epithelial destruction in experimental shigellosis. Infect. Immun. 67:1471-1480.
39. Sansonetti, P. J., T. L. Hale, G. J. Dammin, C. Kapfer, H. H. Collins, and S. B. Formal. 1983. Alterations in the pathogenicity of Escherichia coli K-12 after transfer of plasmid and chromosomal genes from Shigella flexneri. Infect. Immun. 39:1392-1402.
40. Sansonetti, P. J., D. J. Kopecko, and S. B. Formal. 1982. Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect. Immun. 35:852-860.
41. Sansonetti, P. J., and A. Phalipon. 1999. M cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, consequences for the disease process. Semin. Immunol. 11:193-203.
42. Soesatyo, M., J. Biewenga, G. Kraal, and T. Sminia. 1990. The localization of macrophage subsets and dendritic cells in the gastrointestinal tract of the mouse with special reference to the presence of high endothelial venules. An immuno- and enzyme-histochemical study. Cell Tissue Res. 259:587-593.
43. Thirumalai, K., K.-S. Kim, and A. Zychlinsky. 1997. IpaB, a Shigella flexneri invasin, colocalizes with interleukin-1β-converting enzyme in the cytoplasm of macrophages. Infect. Immun. 65:787-793.
44. Van Damme, J., A. Wuyts, G. Froyen, E. Van Coillie, S. Struyf, A. Billiau, P. Proost, J. M. Wang, and G. Opdenakker. 1997. Granulocyte chemotactic protein-2 and related CXC chemokines: from gene regulation to receptor usage. J. Leukoc. Biol. 62:563-569.
45. van de Verg, L. L., C. P. Mallet, H. H. Collins, T. Larsen, C. Hammack, and T. L. Hale. 1995. Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection. Infect. Immun. 63:1947-1954.
46. Voino-Yasenetsky, M. V., and M. K. Voino-Yasenetska. 1961. Experimental pneumonia caused by bacteria of the Shigella group. Acta Morphol. X:440-454.
47. Vokes, S. A., S. A. Reeves, A. G. Torres, and S. M. Payne. 1999. The aerobactin iron transport system genes in Shigella flexneri are present within a pathogenicity island. Mol. Microbiol. 33:63-73.
48. Wassef, J. S., D. F. Keren, and J. L. Mailloux. 1989. Role of M cells in initial antigen uptake and in ulcer formation in rabbit intestinal loop model of shigellosis. Infect. Immun. 57:858-863.
49. Witowski, J., K. Pawlaczyk, A. Breborowicz, A. Scheuren, M. Kuzlan-Pawlaczyk, J. Wisniewska, A. Polubinska, H. Friess, G. M. Gahl, U. Frei, and A. Jorres. 2000. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J. Immunol. 165:5814-5821.
50. World Health Organization. 2003. State of the art of new vaccines: research and development. [Online.] http://www.who.int/vaccine_research/ documents /stateoftheart/en/.
51. Yao, Z., M. K. Spriggs, J. M. Derry, L. Strockbine, L. S. Park, T. VandenBos, J. D. Zappone, S. L. Painter, and R. J. Armitage. 1997. Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 9:794-800.
52. Ye, P., F. H. Rodriguez, S. Kanaly, K. L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver, W. Huang, P. Zhang, J. Zhang, J. E. Shellito, G. J. Bagby, S. Nelson, K. Charrier, J. J. Peschon, and J. K. Kolls. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194:519-527.